Abstract
Cancer treatment has always been a challenge, as local and systemic tumor factors create a complex microenvironment that generates a set of signals impacting infiltrating immune cells. For instance, peripheral blood monocytes from cancer patients tend to transform into immunosuppressive antigen-presenting cells (APCs), where soluble factors "educate" immune cells not to activate efficient…